NEW YORK (GenomeWeb) — Co-Diagnostics announced today that its Logix Smart Zika screening test has received CE-IVD marking, permitting its sale in the EU and other areas that recognize the designation.

The PCR-based test is designed to detect the presence or absence of the Zika virus in serum or plasma collected alongside urine from patients with suspected infection. It will be manufactured at the Salt Lake City, Utah-based firm's ISO 13485:2016-certified facility.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec
12

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.